Atropine for treatment of childhood myopia in India (I-ATOM): multicentric randomized trial.

This multicentric, double-blinded, placebo-controlled randomized clinical trial reports 1-year-data proving efficacy of 0.01% atropine drops in reducing myopia progression (spherical equivalent) in Indian children having mild to moderate myopia without any significant effect on axial length elongation.